Rise I R, Kirkeby O J
Institute for Surgical Research, The National Hospital, Oslo, Norway.
J Neurosurg. 1998 Sep;89(3):448-53. doi: 10.3171/jns.1998.89.3.0448.
The authors tested the hypothesis in a porcine model that inhibition of nitric oxide synthesis during reduced cerebral perfusion pressure (CPP) affected the relative cerebral blood flow (CBF) and the cerebrovascular resistance.
The CPP was reduced by inducing high cerebrospinal fluid pressure and hemorrhagic hypotension. With continuous blood and intracranial pressure monitoring, relative CPP was estimated using the laser Doppler flowmetry technique in nine pigs that received 40 mg/kg nitro-L-arginine methyl ester (L-NAME) and in nine control animals. The L-NAME caused a decrease in relative CBF (p < 0.01) and increases in cerebrovascular resistance (p < 0.01), blood pressure (p < 0.05), and CPP (p < 0.001). During high intracranial pressure there were no significant differences between the treated animals and the controls. After hemorrhage, there was no significant difference between the groups initially, but 30 minutes later the cerebrovascular resistance was decreased in the control group and increased in the L-NAME group relative to baseline (p < 0.05). Combined hemorrhage and high intracranial pressure increased the difference between the two groups with regard to cerebrovascular resistance (p < 0.05).
These results suggest that nitric oxide synthesis inhibition affects the autoregulatory response of the cerebral circulation after cardiovascular compensation has taken place. Nitric oxide synthesis inhibition enhanced the undesirable effects of high intracranial pressure during hypovolemia.
作者在猪模型中验证了以下假设,即在脑灌注压(CPP)降低期间抑制一氧化氮合成会影响相对脑血流量(CBF)和脑血管阻力。
通过诱导高脑脊液压力和出血性低血压来降低CPP。在连续监测血液和颅内压的情况下,使用激光多普勒血流仪技术对9只接受40mg/kg硝基-L-精氨酸甲酯(L-NAME)的猪和9只对照动物进行相对CPP评估。L-NAME导致相对CBF降低(p<0.01),脑血管阻力、血压(p<0.05)和CPP升高(p<0.001)。在高颅内压期间,治疗组动物和对照组之间无显著差异。出血后,两组最初无显著差异,但30分钟后,对照组脑血管阻力相对于基线降低,L-NAME组升高(p<0.05)。出血合并高颅内压增加了两组在脑血管阻力方面的差异(p<0.05)。
这些结果表明,一氧化氮合成抑制在心血管代偿发生后影响脑循环的自动调节反应。一氧化氮合成抑制增强了低血容量期间高颅内压的不良影响。